Stimulation of the amygdalohippocampal complex to treat neurological conditions

• US 8,239,029 B2
• Filed: 10/12/2009
• Issued: 08/07/2012
• Est. Priority Date: 10/21/2004
• Status: Active Grant

• Current Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories)
• Original Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories)
• Inventors: De Ridder, Dirk
• Primary Examiner(s): Layno, Carl H
• Assistant Examiner(s): Stice, Paula J
• Application Number:
  US12/577,640
• Publication Number:
  US 20100057160A1
• Time in Patent Office: 1,030 Days
• Field of Search: 600377-378, 607/45
• US Class Current: 607/45
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: A61N 1/0529 Electrodes for brain stimulation
• CPC Class Codes: A61N 1/0531 Brain cortex electrodes
• CPC Class Codes: A61N 1/0553 Paddle shaped electrodes, e.g. for laminotomy
• CPC Class Codes: A61N 1/36017 with leads or electrodes penetrating the skin
• CPC Class Codes: A61N 1/36021 for treatment of pain
• CPC Class Codes: A61N 1/36036 of the outer, middle or inner ear
• CPC Class Codes: A61N 1/3605 Implantable neurostimulators for stimulating central or peripheral nerve system
• CPC Class Codes: A61N 1/3606 adapted for a particular treatment
• CPC Class Codes: A61N 1/36071 Pain
• CPC Class Codes: A61N 1/36085 Eating disorders or obesity
• CPC Class Codes: A61N 1/36096 Mood disorders, e.g. depression, anxiety or panic disorder
• CPC Class Codes: A61N 1/361 Phantom sensations, e.g. tinnitus
• CPC Class Codes: A61N 1/3611 Respiration control stimulating respiratory organs A61N1/3601
• CPC Class Codes: A61N 1/36117 for treating hypertension
• CPC Class Codes: A61N 2/006 for magnetic stimulation of nerve tissue

Abstract

A system and/or method treating for a neurological disorder by brain region stimulation. The system and/or method comprises a probe and a device to provide stimulation. The probe has a stimulation portion implanted in communication with a predetermined brain region site. The stimulation portion of the probe may be implanted in contact with a predetermined brain region.

Claims

1. A method of treating post traumatic stress disorder (PTSD) in a patient comprising:

identifying the PTSD in the patient;

positioning a stimulation lead within the patient such that at least one electrode of the lead is positioned in or in direct contact with neural tissue of one of a basal nucleus and a lateral nucleus of an amygdala;

generating electrical pulses using an implantable pulse generator (IPG) that is implanted within the patient to conduct electrical pulses from the IPG through the stimulation lead to stimulate the neural tissue of one of the basal nucleus and the lateral nucleus of the amygdala configured to treat the PTSD in the patient; and

determining whether the generating has improved conditions of the PTSD in the patient.

2. A method of alleviating post traumatic stress disorder (PTSD) in a patient comprising:

identifying the PTSD in the patient;

positioning at least an electrical lead within the patient such that at least one electrode of the electrical lead is disposed in or in direct contact with an amygdala brain tissue site selected from the group consisting of basal and lateral nuclei, central nucleus, cortical nuclei, and medial nuclei, and a combination thereof;

selecting a plurality of operating parameters for an electrical stimulation system configured to treat the PTSD;

programming the electrical stimulation system according to the plurality of operating parameters;

activating the electrical stimulation system to deliver electrical pulses to the electrode adjacent to the brain tissue site; and

determining whether the electrical pulses have caused alleviation in symptoms of the PTSD.

3. The method of claim 2 wherein the amygdala brain tissue site is the basal and lateral nuclei.

4. The method of claim 2 further comprising generating, by the IPG, a burst stimulus that comprises a plurality of groups of spike pulses, wherein the burst stimulus is substantially quiescent between the plurality of groups, wherein each spike within each group is separated by a maximum inter-spike interval and each group of spikes is separated by a minimum inter-group interval, wherein the maximum inter-spike interval is 5 milliseconds and the minimum inter-group interval is 20 milliseconds.

5. A method of treating an anxiety disorder in a patient comprising

identifying the anxiety disorder in the patient;

positioning a stimulation lead within the patient such that at least one electrode of the lead is positioned in or in direct contact with neural tissue of at least one of a basal nucleus and a lateral nucleus of an amygdala;

generating electrical pulses using an implantable pulse generator (IPG) that is implanted within the patient to conduct electrical pulses from the IPG through the stimulation lead configured to stimulate the neural tissue of the basal nucleus and the lateral nucleus of the amygdala; and

determining whether the electrical pulses have resulted in effective treatment of the anxiety disorder of the patient.

6. The method of claim 5 wherein the anxiety disorder is selected from the group consisting of post-traumatic stress disorder, panic disorder, obsessive-compulsive disorder, and phobias.

7. The method of claim 6 wherein the anxiety disorder is the post-traumatic stress disorder.